The Pharma Data

MAY 13, 2021

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. De Araujo IE.

Disease 52

Disease Production Testimonials Science 52

Drug & Device Law

DECEMBER 21, 2023

Remember Riegel ( 2008+1 )? Rather than examine the actual bases of those opinions, as Rule 702(b) required, Crockett waved the testimony through with the single observation that the expert claimed to have “conducted a “detailed review of the literature.” He heckled Holley here. CooperSurgical, Inc. 2023 WL 6216933 (S.D.

FDA Approval 52

FDA Approval FDA Drugs Production 52

Drug & Device Law

JUNE 23, 2023

All of them had very stale claims – with that injury occurring before 2008, which was seven years before the critical 2015 label change that added “reports of permanent hair loss” to the drug’s label. Plaintiff Adams’ “sworn testimony and plaintiff fact sheet” established that she blew the statute of limitations by some eight years.

Testimonials 59

Testimonials Government Treatment Production 59

Drug & Device Law

JUNE 1, 2023

We think that they can, and for a state (like Pennsylvania and a number of others) that still follows the “ Frye ” standard looking to the “general acceptance” of expert testimony as the touchstone to admissibility, a Rule 702 state-law equivalent might look something like this: Rule 702. E.g. , Walsh v. BASF Corp. , 3d 446, 461 (Pa.

Testimonials 59

Testimonials Trials Science Government 59

Drug & Device Law

MARCH 23, 2023

Plaintiff also argued that the trial court should have allowed her to offer expert causation testimony from the explanting physician, thus raising an issue of material fact to defeat summary judgment. Southern Source Packaging, LLC , 568 F. 2d 624, 631 (E.D.N.C.

Testimonials 59

Testimonials Packaging Compliance Trials 59

Drug & Device Law

FEBRUARY 20, 2023

Lederle Laboratories , 2008 WL 972657 (W. March 19, 2008) (“It is very difficult to see what else these defendants could have done” when one claimed alternative “was never licensed by the FDA” and the other “was not approved by the FDA until” nearly a decade after plaintiff’s vaccination). 1992) (plaintiff failed “to establish. . .

FDA 59

FDA FDA Approval Testimonials Vaccine 59

Drug & Device Law

JUNE 6, 2022

Thus a confident learned intermediary’s testimony will defeat causation as a matter of law by stating that, notwithstanding a poor result, the treatment provided was standard of care, and even in hindsight they would not do anything different. Confident learned intermediaries stand by their medical decisions. caused anything. 3d 87, 95 (Tex.

Testimonials 59

Testimonials Production Pharmaceuticals Drugs 59